Kalmar, P.J.; Tarkanyi, G.; Karadi, Z.N.; Szapary, L.; Bosnyak, E.
The Impact of Diabetes Mellitus and Admission Hyperglycemia on Clinical Outcomes after Recanalization Therapies for Acute Ischemic Stroke: STAY ALIVE National Prospective Registry. Life 2022, 12, 632.
https://doi.org/10.3390/life12050632
AMA Style
Kalmar PJ, Tarkanyi G, Karadi ZN, Szapary L, Bosnyak E.
The Impact of Diabetes Mellitus and Admission Hyperglycemia on Clinical Outcomes after Recanalization Therapies for Acute Ischemic Stroke: STAY ALIVE National Prospective Registry. Life. 2022; 12(5):632.
https://doi.org/10.3390/life12050632
Chicago/Turabian Style
Kalmar, Peter Janos, Gabor Tarkanyi, Zsofia Nozomi Karadi, Laszlo Szapary, and Edit Bosnyak.
2022. "The Impact of Diabetes Mellitus and Admission Hyperglycemia on Clinical Outcomes after Recanalization Therapies for Acute Ischemic Stroke: STAY ALIVE National Prospective Registry" Life 12, no. 5: 632.
https://doi.org/10.3390/life12050632
APA Style
Kalmar, P. J., Tarkanyi, G., Karadi, Z. N., Szapary, L., & Bosnyak, E.
(2022). The Impact of Diabetes Mellitus and Admission Hyperglycemia on Clinical Outcomes after Recanalization Therapies for Acute Ischemic Stroke: STAY ALIVE National Prospective Registry. Life, 12(5), 632.
https://doi.org/10.3390/life12050632